Clinical Trial Update: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older [Phase 3]

View source ↗

Summary

Phase 3 trial comparing lacosamide to carbamazepine-CR as initial monotherapy in epilepsy shows results completed with posted findings in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide (Lacosamide)
• carbamazepine controlled-release (carbamazepine)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Epilepsy, Monotherapy | Phase 3 | Status: COMPLETED | Results posted: 2016-02-23